Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma

PURPOSE: The purpose of this study was to better understand the efficacy and safety of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma(R/RMM). METHODS: We retrieved and reviewed published reports including carfilzomib, panobinostat, and el...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Hematol Oncol
Asıl Yazarlar: Liu, Liping, Zhao, Ningning, Xu, Wenjun, Sheng, Zhixin, Wang, Lida
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Letter to the Editor
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941034/
https://ncbi.nlm.nih.gov/pubmed/27405295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0286-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller